Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Moderna Sues Pfizer and BioNTech Over Covid Vaccine Technology

Published 08/27/2022, 12:54 AM
© Reuters

By Sam Boughedda

Moderna (NASDAQ:MRNA) announced Friday that it is suing Pfizer (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) for patent infringements filed between 2010 and 2016 covering its mRNA technology.

The drugmaker filed the patent infringement lawsuits in the United States District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany.

Moderna said that "Pfizer and BioNTech copied this technology, without Moderna's permission," copying two features that are "critical to the success of mRNA vaccines."

They claim that out of the four vaccine candidates Pfizer and BioNTech were looking at, they proceeded with a vaccine that has "the same exact mRNA chemical modification to its vaccine as Spikevax," Moderna's vaccine.

"We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the COVID-19 pandemic," said Moderna Chief Executive Officer Stéphane Bancel.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.